| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,916 |
2,606 |
$220K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,318 |
2,893 |
$195K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,078 |
1,912 |
$145K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,087 |
1,039 |
$99K |
| 87428 |
|
1,334 |
1,044 |
$45K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,214 |
1,073 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
897 |
420 |
$14K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
676 |
554 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,859 |
1,666 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
154 |
127 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
618 |
243 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
200 |
160 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
61 |
60 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
135 |
112 |
$2K |
| 81025 |
|
82 |
80 |
$534.06 |
| 0011A |
|
14 |
13 |
$520.00 |
| 71046 |
Radiologic examination, chest; 2 views |
15 |
15 |
$344.04 |
| 99000 |
|
18 |
14 |
$271.63 |
| 81003 |
|
57 |
54 |
$197.00 |
| 90686 |
|
29 |
29 |
$184.78 |
| 90756 |
|
13 |
13 |
$79.23 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
15 |
12 |
$20.02 |
| H0033 |
Oral medication administration, direct observation |
68 |
68 |
$10.00 |
| 91301 |
|
14 |
13 |
$0.00 |
| 91300 |
|
14 |
12 |
$0.00 |